Molecular Partners (NASDAQ:MOLN) Earns Outperform Rating from Analysts at Lifesci Capital
Lifesci Capital began coverage on shares of Molecular Partners (NASDAQ:MOLN – Free Report) in a report issued on Tuesday morning,Benzinga reports. The firm issued an outperform rating and a $12.00 price objective on the stock. Molecular Partners Trading Down 0.5 % Shares of NASDAQ MOLN opened at $4.62 on Tuesday. Molecular Partners has a twelve […]
Lifesci Capital began coverage on shares of Molecular Partners (NASDAQ:MOLN – Free Report) in a report issued on Tuesday morning,Benzinga reports. The firm issued an outperform rating and a $12.00 price objective on the stock. Molecular Partners Trading Down 0.5 % Shares of NASDAQ MOLN opened at $4.62 on Tuesday. Molecular Partners has a twelve […]
